Lv4
574 积分 2023-03-18 加入
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use
11天前
已完结
Medoxomil Prodrug Strategies
11天前
已完结
The long and winding road of designing phosphodiesterase inhibitors for the treatment of heart failure
13天前
已完结
Cardiac Troponin Activator CK-963 Increases Cardiac Contractility in Rats
13天前
已完结
Design, Synthesis, and Evaluation of Selective PDE4 Inhibitors for the Therapy of Pulmonary Injury
20天前
已完结
Mangostanin Derivatives as Novel and Orally Active Phosphodiesterase 4 Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis with Improved Safety
20天前
已完结
Neutral LPAR1 Antagonists for the Treatment of Idiopathic Pulmonary Fibrosis
20天前
已完结
The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors
20天前
已完结
Diester Prodrugs of a Phosphonate Butyrophilin Ligand Display Improved Cell Potency, Plasma Stability, and Payload Internalization
1个月前
已完结
Enhanced Plasma Stability and Potency of Aryl/Acyloxy Prodrugs of a BTN3A1 Ligand
1个月前
已完结
皖公网安备34019202002308
